C. Gilbert and A. Foster, Childhood blindness in the context of VISION 2020 -the right to sight, Bull World Health Organ, vol.79, issue.3, pp.227-232, 2001.

W. A. Van-heuven and J. W. Kiel, ROP surgery and ocular circulation, Eye, vol.22, issue.10, pp.1267-1272, 2008.

E. Kermorvant-duchemin, P. Sapieha, and M. Sirinyan, Understanding ischemic retinopathies: emerging concepts from oxygen-induced retinopathy, Doc Ophthalmol, vol.120, issue.1, pp.51-60, 2010.

A. Madan and J. S. Penn, Animal models of oxygen-induced retinopathy, Front Biosci, vol.8, pp.1030-1043, 2003.

M. L. Chen, L. Guo, L. E. Smith, C. E. Dammann, and O. Dammann, High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysis, Pediatrics, vol.125, issue.6, pp.1483-1492, 2010.

J. Chen and L. E. Smith, Retinopathy of prematurity, Angiogenesis, vol.10, issue.2, pp.133-140, 2007.

P. Sapieha, D. Hamel, and Z. Shao, Proliferative retinopathies: angiogenesis that blinds, Int J Biochem Cell Biol, vol.42, issue.1, pp.5-12, 2010.

A. B. Fulton, R. M. Hansen, A. Moskowitz, and A. M. Barnaby, Multifocal ERG in subjects with a history of retinopathy of prematurity, Doc Ophthalmol, vol.111, issue.1, pp.7-13, 2005.

R. M. Siatkowski, V. Dobson, G. E. Quinn, C. G. Summers, E. A. Palmer et al., Severe visual impairment in children with mild or moderate retinal residua following regressed threshold retinopathy of prematurity, J AAPOS, vol.11, issue.2, pp.148-152, 2007.

V. Dobson, G. E. Quinn, and I. Abramov, Color vision measured with pseudoisochromatic plates at five-and-a-half years in eyes of children from the CRYO-ROP study, Invest Ophthalmol Vis Sci, vol.37, issue.12, pp.2467-2474, 1996.

A. B. Fulton, R. M. Hansen, R. A. Petersen, and D. K. Vanderveen, The rod photoreceptors in retinopathy of prematurity: an electroretinographic study, Arch Ophthalmol, vol.119, issue.4, pp.499-505, 2001.

A. B. Fulton, R. M. Hansen, and A. Moskowitz, Development of rod function in term born and former preterm subjects, Optom Vis Sci, vol.86, issue.6, pp.653-658, 2009.

F. M. Recchia and C. C. Recchia, Foveal dysplasia evident by optical coherence tomography in patients with a history of retinopathy of prematurity, Retina, vol.27, issue.9, pp.1221-1226, 2007.

G. P. Soong, M. Shapiro, W. Seiple, and J. P. Szlyk, Macular structure and vision of patients with macular heterotopia secondary to retinopathy of prematurity, Retina, vol.28, issue.8, pp.1111-1116, 2008.

P. S. Baker and W. Tasman, Optical coherence tomography imaging of the fovea in retinopathy of prematurity, Ophthalmic Surg Lasers Imaging, vol.41, issue.2, pp.201-206, 2010.

J. S. Penn, M. M. Henry, and B. L. Tolman, Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat, Pediatr Res, vol.36, issue.6, pp.724-731, 1994.

B. A. Berkowitz and J. S. Penn, Abnormal panretinal response pattern to carbogen inhalation in experimental retinopathy of prematurity, Invest Ophthalmol Vis Sci, vol.39, issue.5, pp.840-845, 1998.

P. Lachapelle, O. Dembinska, L. M. Rojas, J. Benoit, and G. Almazan, Chemtob S. Persistent functional and structural retinal anomalies in newborn rats exposed to hyperoxia, Can J Physiol Pharmacol, vol.77, issue.1, pp.48-55, 1999.

A. L. Dorfman, A. Polosa, S. Joly, S. Chemtob, and P. Lachapelle, Functional and structural changes resulting from strain differences in the rat model of oxygen-induced retinopathy, Invest Ophthalmol Vis Sci, vol.50, issue.5, pp.2436-2450, 1009.

A. Dorfman, N. Cuenca, I. Pinilla, S. Chemtob, and P. Lachapelle, Immunohistochemical evidence of synaptic retraction, cytoarchitectural remodelling and cell death in the inner retina of the rat model of OIR, Invest Ophthalmol Vis Sci, vol.52, pp.1693-1708, 2011.

D. Y. Yu, S. J. Cringle, V. Alder, and E. N. Su, Intraretinal oxygen distribution in the rat with graded systemic hyperoxia and hypercapnia, Invest Ophthalmol Vis Sci, vol.40, issue.9, pp.2082-2087, 1999.

P. Hardy, A. M. Nuyt, D. Abran, J. St-louis, D. R. Varma et al., Nitric oxide in retinal and choroidal blood flow autoregulation in newborn pigs: interactions with prostaglandins, Pediatr Res, vol.39, issue.3, pp.487-493, 1996.

I. Dumont, P. Hardy, and K. G. Peri, Regulation of endothelial nitric oxide synthase by PGD(2) in the developing choroid, Am J Physiol Heart Circ Physiol, vol.278, issue.1, pp.60-66, 2000.

P. Hardy, K. G. Peri, I. Lahaie, D. R. Varma, and S. Chemtob, Increased nitric oxide synthesis and action preclude choroidal vasoconstriction to hyperoxia in newborn pigs, Circ Res, vol.79, issue.3, pp.504-511, 1996.

N. A. Sharif, T. L. Davis, and G. W. Williams, Ocular hypotensive DP-class prostaglandin receptor affinities determined by quantitative autoradiography on human eye sections, J Ocul Pharmacol Ther, vol.21, issue.2, pp.121-132, 2005.

N. A. Sharif, G. W. Williams, and T. L. Davis, Pharmacology and autoradiography of human DP prostanoid receptors using, Br J Pharmacol, vol.131, issue.3, pp.1025-1038, 2000.

P. Hardy, I. Dumont, and M. Bhattacharya, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy, Cardiovasc Res, vol.18, issue.3, pp.489-509, 2000.

M. H. Beauchamp, F. Sennlaub, and G. Speranza, Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy, Free Radic Biol Med, vol.37, issue.11, pp.1885-1894, 2004.

G. L. Milne, E. S. Musiek, and J. D. Morrow, The cyclopentenone (A2/J2) isoprostanes-unique, highly reactive products of arachidonate peroxidation, Antioxid Redox Signal, vol.7, issue.1-2, pp.210-220, 2005.

N. E. , Lipid peroxidation: physiological levels and dual biological effects, Free Radic Biol Med, vol.47, issue.5, pp.469-484, 2009.

T. S. Lee, H. L. Tsai, and L. Y. Chau, Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2, J Biol Chem, vol.278, issue.21, pp.19325-19330, 2003.

A. Landar, J. W. Zmijewski, and D. A. Dickinson, Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species, Am J Physiol Heart Circ Physiol, vol.290, issue.5, pp.1777-1787, 2006.

J. Y. Oh, N. Giles, A. Landar, and V. Darley-usmar, Accumulation of 15-deoxy-delta(12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction, Biochem J, vol.411, issue.2, pp.297-306, 2008.

D. W. Gilroy, P. R. Colville-nash, D. Willis, J. Chivers, M. J. Paul-clark et al., Inducible cyclooxygenase may have anti-inflammatory properties, Nat Med, vol.6, pp.698-701, 1999.

Y. Chen, J. D. Morrow, and L. J. Roberts, Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway, J Biol Chem, vol.274, issue.16, pp.10863-10868, 1999.

A. L. Levonen, D. A. Dickinson, D. R. Moellering, R. T. Mulcahy, H. J. Forman et al., Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells, Arterioscler Thromb Vasc Biol, vol.21, issue.11, pp.1846-1851, 2001.

W. Erl, C. Weber, and A. Zernecke, Cyclopentenone prostaglandins induce endothelial cell apoptosis independent of the peroxisome proliferator-activated receptor-gamma, Eur J Immunol, vol.34, issue.1, pp.241-250, 2004.

P. Geisen, L. J. Peterson, D. Martiniuk, A. Uppal, Y. Saito et al., Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity, Mol Vis, vol.14, pp.345-357, 2008.

J. R. Mccolm, P. Geisen, and M. E. Hartnett, VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP, Mol Vis, vol.10, pp.512-520, 2004.

S. R. Montezuma, D. Vavvas, and J. W. Miller, Review of the ocular angiogenesis animal models, Semin Ophthalmol, vol.24, issue.2, pp.52-61, 20090.

A. Dorfman, O. Dembinska, S. Chemtob, and P. Lachapelle, Early manifestations of postnatal hyperoxia on the retinal structure and function of the neonatal rat, Invest Ophthalmol Vis Sci, vol.49, issue.1, pp.458-466, 2008.

J. Browning, C. K. Wylie, and G. Gole, Quantification of oxygen-induced retinopathy in the mouse, Invest Ophthalmol Vis Sci, vol.38, issue.6, pp.1168-1174, 1997.

Y. Fei, Development of the cone photoreceptor mosaic in the mouse retina revealed by fluorescent cones in transgenic mice, Mol Vis, vol.15, issue.9, pp.31-42, 2003.

Q. Xu, T. Qaum, and A. P. Adamis, Sensitive blood-retinal barrier breakdown quantitation using Evans blue, Invest Ophthalmol Vis Sci, vol.42, issue.3, pp.789-794, 2001.

T. Krucker, A. Lang, and E. P. Meyer, New polyurethane-based material for vascular corrosion casting with improved physical and imaging characteristics, Microsc Res Tech, vol.69, issue.2, pp.138-147, 2006.

S. Kotamraju, E. A. Konorev, J. Joseph, and B. Kalyanaraman, Doxorubicininduced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen: role of reactive oxygen and nitrogen species, J Biol Chem, vol.275, issue.43, pp.33585-33592, 2000.

S. L. Hempel, G. R. Buettner, Y. Q. O'malley, D. A. Wessels, and D. M. Flaherty, Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2?,7?-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2?,7?-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123, Free Radic Biol Med, vol.27, issue.1-2, pp.146-159, 1999.

F. Sennlaub, F. Valamanesh, and A. Vazquez-tello, Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy, Circulation, vol.108, issue.2, pp.198-204, 2003.
URL : https://hal.archives-ouvertes.fr/inserm-00150824

O. Dembinska, L. M. Rojas, D. R. Varma, S. Chemtob, and P. Lachapelle, Graded contribution of retinal maturation to the development of oxygen-induced retinopathy in rats, Invest Ophthalmol Vis Sci, vol.42, issue.5, pp.1111-1118, 2001.

P. Hardy, M. Beauchamp, and F. Sennlaub, Inflammatory lipid mediators in ischemic retinopathy, Pharmacol Rep, vol.57, pp.169-190, 2005.

X. Xin, S. Yang, J. Kowalski, and M. E. Gerritsen, Peroxisome proliferatoractivated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo, J Biol Chem, vol.274, issue.13, pp.9116-9121, 1999.

S. A. Kliewer, J. M. Lenhard, T. M. Willson, I. Patel, D. C. Morris et al., A prostaglandin J2 metabolite binds peroxisome proliferatoractivated receptor gamma and promotes adipocyte differentiation, Cell, vol.83, issue.5, pp.813-819, 1995.

O. Ates, H. H. Alp, and I. Caner, Oxidative DNA damage in retinopathy of prematurity, Eur J Ophthalmol, vol.19, issue.1, pp.80-85, 2009.

S. H. Koh, B. Jung, C. W. Song, Y. Kim, Y. S. Kim et al., 15-Deoxy-delta12,14-prostaglandin J2, a neuroprotectant or a neurotoxicant?, Toxicology, vol.216, issue.2-3, pp.232-243, 2005.

J. Gayarre, M. I. Avellano, F. J. Sanchez-gomez, M. J. Carrasco, F. J. Canada et al., Modification of proteins by cyclopentenone prostaglandins is differentially modulated by GSH in vitro, Ann N Y Acad Sci, vol.1096, pp.78-85, 2007.

D. S. Reisner, R. M. Hansen, O. Findl, R. A. Petersen, and A. B. Fulton, Darkadapted thresholds in children with histories of mild retinopathy of prematurity, Invest Ophthalmol Vis Sci, vol.38, issue.6, pp.1175-1183, 1997.

A. B. Fulton, R. M. Hansen, A. Moskowitz, and J. D. Akula, The neurovascular retina in retinopathy of prematurity, Prog Retin Eye Res, vol.28, issue.6, pp.452-482, 2009.

M. Saint-geniez, D. 'amore, and P. A. , Development and pathology of the hyaloid, choroidal and retinal vasculature, Int J Dev Biol, vol.48, issue.8 -9, pp.1045-1058, 2004.

Z. Dreher, S. R. Robinson, and C. Distler, Muller cells in vascular and avascular retinae: a survey of seven mammals, J Comp Neurol, vol.323, issue.1, pp.59-80, 1992.

S. Zhao and P. A. Overbeek, Regulation of choroid development by the retinal pigment epithelium, Mol Vis, vol.7, pp.277-282, 2001.

M. Sirinyan, F. Sennlaub, and A. Dorfman, Hyperoxic exposure leads to nitrative stress and ensuing microvascular degeneration and diminished brain mass and function in the immature subject, Stroke, vol.37, issue.11, pp.2807-2815, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00150829

M. H. Beauchamp, A. K. Martinez-bermudez, F. Gobeil, and . Jr, Role of thromboxane in retinal microvascular degeneration in oxygeninduced retinopathy, J Appl Physiol, vol.90, issue.6, pp.2279-2288, 2001.

J. Pfitzner, Poiseuille and his law, Anaesthesia, vol.31, issue.2, pp.273-275, 1976.

B. Pemp and L. Schmetterer, Ocular blood flow in diabetes and agerelated macular degeneration, Can J Ophthalmol, vol.43, issue.3, pp.295-301, 2008.

J. Sharma, S. M. Barr, Y. Geng, Y. Yun, and R. D. Higgins, Ibuprofen improves oxygen-induced retinopathy in a mouse model, Curr Eye Res, vol.27, issue.5, pp.309-314, 2003.

D. S. Mcleod, R. Brownstein, and G. A. Lutty, Vaso-obliteration in the canine model of oxygen-induced retinopathy, Invest Ophthalmol Vis Sci, vol.37, issue.2, pp.300-311, 1996.

T. R. Vrabec, J. A. Mcnamara, R. C. Eagle, and W. Tasman, Cryotherapy for retinopathy of prematurity: a histopathologic comparison of a treated and untreated eye, Ophthalmic Surg, vol.25, issue.1, pp.38-41, 1994.

J. Cao, S. Mcleod, C. A. Merges, and G. A. Lutty, Choriocapillaris degeneration and related pathologic changes in human diabetic eyes, Arch Ophthalmol, vol.116, issue.5, pp.589-597, 1998.

N. Tsuji, T. Matsuura, K. Ozaki, T. Sano, and I. Narama, Diabetic retinopathy and choroidal angiopathy in diabetic rats (WBN/Kob), Exp Anim, vol.58, issue.5, pp.481-487, 2009.

E. S. Musiek, G. L. Milne, B. Mclaughlin, and J. D. Morrow, Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity, Brain Pathol, vol.15, issue.2, pp.149-158, 2005.

M. Kondo, T. Oya-ito, T. Kumagai, T. Osawa, and K. Uchida, Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress, J Biol Chem, vol.276, issue.15, pp.12076-12083, 2001.

L. Johnson, G. E. Quinn, S. Abbasi, J. Gerdes, F. W. Bowen et al., Severe retinopathy of prematurity in infants with birth weights less than 1250 grams: incidence and outcome of treatment with pharmacologic serum levels of vitamin E in addition to cryotherapy from 1985 to 1991, J Pediatr, vol.127, issue.4, pp.632-639, 1995.

D. S. Mcleod, M. Taomoto, T. Otsuji, W. R. Green, J. S. Sunness et al., Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration, Invest Ophthalmol Vis Sci, vol.43, issue.6, pp.1986-1993, 2001.

A. L. Dorfman, S. Chemtob, and P. Lachapelle, Postnatal hyperoxia and the developing rat retina: beyond the obvious vasculopathy, Doc Ophthalmol, vol.120, issue.1, pp.61-66, 2010.

A. B. Fulton and R. M. Hansen, Photoreceptor function in infants and children with a history of mild retinopathy of prematurity, J Opt Soc Am A Opt Image Sci Vis, vol.13, issue.3, pp.566-571, 1996.

J. M. Barnett, S. E. Yanni, and J. S. Penn, The development of the rat model of retinopathy of prematurity, Doc Ophthalmol, vol.120, issue.1, pp.3-12, 2010.

J. Wallman, C. Wildsoet, and A. Xu, Moving the retina: choroidal modulation of refractive state, Vision Res, vol.35, issue.1, pp.37-50, 1995.